[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100529120":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":12,"centralContacts":17,"locations":26,"responsibleParty":46,"collaborators":10,"id":48,"slug":49,"hasResults":50,"nctId":51,"briefTitle":52,"officialTitle":52,"acronym":53,"eligibilityCriteria":54,"healthyVolunteers":50,"sex":55,"minAge":56,"maxAge":57,"enrollmentInfo":58,"targetDuration":10,"studyType":61,"phases":10,"briefSummary":62,"conditions":63,"keywords":65,"overallStatus":29,"whyStopped":10,"lastUpdateSubmitDate":72,"lastUpdatePostDateStruct":73,"startDateStruct":76,"completionDateStruct":78,"leadSponsor":80,"locationsCount":81},{"fullName":5,"class":6},"Sheffield Teaching Hospitals NHS Foundation Trust","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"Chemotherapy-treated GTN Patients",null,"Patients with a diagnosis of Gestational Trophoblastic Neoplasia who completed chemotherapy treatment between 6 weeks and 24 months prior to the study. No IMP intervention to be administered, patients to be involved in a qualitative interview.",[13],{"name":14,"affiliation":15,"role":16},"Kamaljit Singh","Nurse Consultant","PRINCIPAL_INVESTIGATOR",[18,22],{"name":14,"role":19,"phone":20,"phoneExt":10,"email":21},"CONTACT","01142265274","kamaljitsingh@nhs.net",{"name":23,"role":19,"phone":24,"phoneExt":10,"email":25},"Grace Cole","01142711899","grace.cole1@nhs.net",[27],{"facility":28,"status":29,"city":30,"state":31,"zip":32,"country":33,"countryCode":34,"cosmosGeoPoint":35,"geoPoint":40,"contacts":41},"Weston Park Hospital","RECRUITING","Sheffield","South Yorkshire","S10 2SJ","United Kingdom","UK",{"type":36,"coordinates":37},"Point",[38,39],-1.4659,53.38297,{"lat":39,"lon":38},[42,43],{"name":14,"role":19,"phone":20,"phoneExt":10,"email":21},{"name":44,"role":19,"phone":10,"phoneExt":10,"email":45},"Daniel Habershon","sth.specialisedcancerresearchadministration@nhs.net",{"type":47,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100529120","the-psychological-impact-of-gtn-on-women-who-have-completed-chemotherapy-treatment-100529120",false,"NCT06169644","The Psychological Impact of GTN on Women Who Have Completed Chemotherapy Treatment","PI-GTN","Inclusion Criteria:\n\n* Treated with chemotherapy for a GTN diagnosis\n* Completed treatment between 6 weeks and 24 months\n* Are able to provide informed consent\n* Have no cognitive impairment as judged by the treating clinician\n\nExclusion Criteria:\n\n* Treatment received less than 6 weeks ago\n* Treatment received more than 24 months ago\n* Non-English speaking","FEMALE","16 Years","55 Years",{"count":59,"type":60},20,"ESTIMATED","OBSERVATIONAL","A cross-sectional retrospective study of a sample of 20 women who completed single agent or multi agent chemotherapy: between 6 weeks and 24 months post treatment involving a semi structured telephone interview. A patient sample of 20 is proposed for the study. These are all the patients who meet the inclusion criteria below and are thus eligible for the study. These patients will be contacted via telephone by the principal investigator to inform them of the study and invite participation. A proposed sample size of 20 is sufficient to generate data to address the central questions and furthermore, this sample size is adequate because the intention is to gain insight into the experiences of patients' perceptions about their psychological experiences.\n\nObjectives:\n\n* Gaining insight into the emotional impact of GTN post treatment\n* Ascertaining if health professionals are providing adequate psychological support\n* Identifying sources of support that patients accessed post completion of treatment\n* Identifying potential areas of improvement in the follow up support for future patients\n\nCriteria for inclusion:\n\n* Treated with chemotherapy for a GTN diagnosis\n* Completed treatment between 6 weeks and 24 months\n* Are able to provide informed consent\n* Have no cognitive impairment as judged by the treating clinician\n\nCriteria for exclusion\n\n* Treatment received less than 6 weeks ago\n* Treatment received more than 24 months ago\n* Non-English speaking\n\nOutcome measures are not appropriate in this qualitative study. However outputs from this study include increasing knowledge and insight into:\n\n* patients' experiences of their psychological experiences post chemotherapy\n* patients' perspective of the support received after their treatment\n* potential areas of improvements in care",[64],"Gestational Trophoblastic Neoplasia",[66,67,68,69,70,71],"Gestational","Trophoblastic","Disease","Neoplasia","GTD","GTN","2025-02-20",{"date":74,"type":75},"2025-02-21","ACTUAL",{"date":77,"type":75},"2024-05-15",{"date":79,"type":60},"2025-12-31",{"name":5,"class":6},1]